These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7004666)

  • 21. Insulin therapy in relation to circulating C-peptide levels.
    Beischer W; Kerner W; Raptis S; Keller L; Beischer B; Pfeiffer EF
    Diabetes; 1978; 27 Suppl 1():235-40. PubMed ID: 415925
    [No Abstract]   [Full Text] [Related]  

  • 22. Factitious hyperinsulinism leading to pancreatectomy: severe forms of Munchausen syndrome by proxy.
    Giurgea I; Ulinski T; Touati G; Sempoux C; Mochel F; Brunelle F; Saudubray JM; Fekete C; de Lonlay P
    Pediatrics; 2005 Jul; 116(1):e145-8. PubMed ID: 15995015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I; Niskanen L; Knip M; Mykkänen LM; Haffner S; Uusitupa M; Laakso M
    Eur J Endocrinol; 2005 Aug; 153(2):265-73. PubMed ID: 16061833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 25. [The clinical value of C-peptide assay (author's transl)].
    Vialettes B; Vague P
    Diabete Metab; 1980 Sep; 6(3):225-9. PubMed ID: 7002655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a common standard for comparison of insulin C-peptide measurements by different laboratories.
    Caygill CP; Gaines Das RE; Bangham DR
    Diabetologia; 1980 Mar; 18(3):197-204. PubMed ID: 6245983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of surreptitious administration of analog insulin to an 8-week-old infant.
    Green RP; Hollander AS; Thevis M; Thomas A; Dietzen DJ
    Pediatrics; 2010 May; 125(5):e1236-40. PubMed ID: 20385635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma C peptide in hyperinsulinaemic hypoglycaemia.
    Bommen M; Stanhope R; Kurtz AB; Brook CG
    Arch Dis Child; 1984 Nov; 59(11):1096-8. PubMed ID: 6391393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood CPR levels in diabetes mellitus during insulin therapy, with special reference to the characteristics of PLC (proinsulin-like components) and C-peptide in fractional analysis].
    Oyama H; Nakajima Y; Amagu A; Matsumura S; Nishida S
    Horumon To Rinsho; 1977 Oct; 25(10):1107-12. PubMed ID: 589809
    [No Abstract]   [Full Text] [Related]  

  • 30. A soluble-phase proinsulin radioimmunoassay and its use in diagnosis of hypoglycaemia.
    Naylor BA; Matthews DR; Turner RC
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():352-63. PubMed ID: 3310832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of C-peptide immunoreactivity in plasma of normal subjects after trypsin action.
    Beck B; Villaume C; Debry G
    Diabete Metab; 1980 Mar; 6(1):25-9. PubMed ID: 6989659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic control in diabetic patients. Effect of insulin-secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodies.
    Gonen B; Goldman J; Baldwin D; Goldberg RB; Ryan WG; Blix PM; Schanzlin D; Fritz KJ; Rubenstein AH
    Diabetes; 1979 Aug; 28(8):749-53. PubMed ID: 446933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
    Beischer W
    Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of organic hyperinsulinism].
    Arnold R; Rothmund M
    Dtsch Med Wochenschr; 1989 Mar; 114(12):464-7. PubMed ID: 2538302
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.
    Rubenstein AH; Kuzuya H; Horwitz DL
    Arch Intern Med; 1977 May; 137(5):625-32. PubMed ID: 193451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy.
    Sandler R; Horwitz DL; Rubenstein AH; Kuzuya H
    Am J Med; 1975 Nov; 59(5):730-6. PubMed ID: 1200040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
    Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S
    Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sensitive radioimmunoassay for human proinsulin, with sequential use of antisera to C-peptide and insulin.
    Ward WK; Paquette TL; Frank BH; Porte D
    Clin Chem; 1986 May; 32(5):728-33. PubMed ID: 3516448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-peptide in conditions other than diabetes mellitus.
    Horwitz DL; Rubenstein AH; Mako ME; Cruz A; Blix PM
    Diabetes; 1978; 27 Suppl 1():267-71. PubMed ID: 631444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.